6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed ... ) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... Jiawei Tan, MD #Guideline ... #CKD #HFrEF #management
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #medications #table
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... , guideline-directed
Dilated Common Bile Duct on POCUS
50's yo patient with RUQ abd pain. Vitals stable/afebrile. Labs: WBC
Common Bile Duct on POCUS ... Vitals stable/afebrile ... mass in distal CBD ... RJonesSonoEM #Dilated #CBD ... #POCUS #ultrasound
Algorithm for choosing the appropriate candidate for stress testing in patients with suspected coronary artery disease
artery disease (CAD ... with suspected CAD ... based on ACC/AHA guidelines ... evaluation of stable ... ACS #stresstest #CAD